Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Alabama Oncology
Birmingham Alabama 35211

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

University of Alabama at Birmingham
Birmingham Alabama 35294

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Southern Cancer Center
Mobile Alabama 36608

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More ▼

UPDATED

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study evaluating Neratinib and Loperamide for the treatment of Early Stage HER2+ Breast Cancer

UPDATED

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

UPDATED

Mobile Alabama 36604

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Birmingham Alabama 35294

A clinical research study of Trastuzumab, pertuzumab and lapatinib for the treatment of Breast Neoplasms

Birmingham Alabama 35294-0006

A clinical trial seeking patients for a research study for the treatment of Breast Cancer

Birmingham Alabama 35249-3300

A clinical trial to evaluate treatments for patients with Metastatic Breast Cancer

Birmingham Alabama 35294

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Birmingham Alabama 35211

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Birmingham Alabama 35205

A clinical trial to evaluate treatments using Ointment and 0.1% Uracil Ointment for patients with Palmar-Plantar Erythrodysesthesia or Breast Cancer

Birmingham Alabama 35294

A clinical trial to evaluate treatments using ONT-380 and T-DM1 for patients with HER2 Positive Breast Cancers

Birmingham Alabama

A clinical trial to evaluate treatments using Ruxolitinib, Capecitabine and Placebo for patients with Advanced or Metastatic HER2-negative Breast Cancer

Birmingham Alabama 35294

A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-LIV1A to evaluate Breast Cancer

Mobile Alabama 36608

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Mobile Alabama 36604

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Mobile Alabama 36688

A clinical trial to evaluate treatments using TAC chemotherapy, TC chemotherapy, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy and TCH chemotherapy for patients with Breast Cancer

Mobile Alabama 36688

Patients are needed to participate in a clinical research study of Fulvestrant, BKM120 and BKM120 matching placebo to evaluate Metastatic Breast Cancer HR+, HER2-

Mobile Alabama

Patients are needed to participate in a clinical research study of Olaparib and Physician's choice chemotherapy to evaluate Breast Cancer Metastatic

Alaska

UPDATED

Anchorage Alaska 99508

A clinical research study of trastuzumab emtansine and trastuzumab for the treatment of Breast Cancer

Arizona

Arizona Center for Cancer Care
Glendale Arizona 85306

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Research Site
Phoenix Arizona

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Arizona Cancer Research Alliance
Scottsdale Arizona 85251

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Research Site
Tucson Arizona

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Arizona Cancer Center
Tucson Arizona 85724

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

Yuma Regional Cancer Center
Yuma Arizona 85364

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More ▼

UPDATED

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Abemaciclib, Anastrozole, Letrozole and Placebo to evaluate Breast Cancer

UPDATED

Scottsdale Arizona

A clinical trial seeking patients for a research study for the treatment of Breast Cancer, Non-Small Cell Lung Cancer or Pancreatic Cancer

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Metastatic Breast Cancer

UPDATED

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

UPDATED

Sedona Arizona 86336

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

UPDATED

Tucson Arizona 85710

A Phase 3 clinical study for patients with Metastatic Breast Cancer

UPDATED

Tucson Arizona 85715

Patients are needed to participate in a clinical research study of Abemaciclib, Anastrozole, Letrozole and Placebo to evaluate Breast Cancer

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study to evaluate Breast Cancer

Chandler Arizona

A clinical trial to evaluate treatments using Ruxolitinib, Capecitabine and Placebo for patients with Advanced or Metastatic HER2-negative Breast Cancer

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Fulvestrant, BKM120 and BKM120 matching placebo to evaluate Metastatic Breast Cancer HR+, HER2-

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with Metastatic Breast Cancer

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study evaluating Eniluracil, 5-Fluorouracil, Leucovorin and Capecitabine for the treatment of Metastatic Breast Cancer

Goodyear Arizona 85338

A clinical trial to evaluate treatments using BMN 673 for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

Phoenix Arizona 85013

A clinical study for patients with Breast Cancer

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Blood collection for the treatment of Metastatic Breast Cancer

Scottsdale Arizona 85259

A clinical study for patients with Breast Cancer

Scottsdale Arizona

A clinical research study for the treatment of Breast Cancer or HER2 Positive Breast Cancer

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using BMN 673 and Physician's-Choice for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

Scottsdale Arizona 85251

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using FFDM Mammography and DBT Mammography for patients with Breast Cancer

Scottsdale Arizona 85259

A Phase 1 clinical study for patients using CX-4945 oral formulation